The correctors lumacaftor (VX809), tezacaftor (VX661), and elexacaftor (VX445) and the potentiator ivacaftor (VX770) are the four CFTR modulators that have successfully progressed through clinical trials and are currently used in the therapy of CF [26,27,28,29]. This evidence concerns the gene CFTR and cystic fibrosis.